Abnormalities of Cytokine Receptor Signalling Contributing to Diseases of Red Blood Cell Production

References

• Muta K, Krantz S B, Bondurant M C, Dai C-H. Stem cell factor retards differentiation of normal human erythroid progenitor cells while stimulating proliferation. Blood 1995; 86: 572–80
   PubMed Web of Science ®Google Scholar
• Nocka K, Majumder S, Chabot B, Ray P, Cervone M, Bernstein A, et al. Expression of c-kit gene products in known cellular targets of W mutations in normal and W mutant mice - evidence for an impaired c-kit kinase in mutant mice. Genes Dev 1989; 3: 816–26
   PubMed Web of Science ®Google Scholar
• Wu H, Liu X, Jaenisch R, Lodish H F. Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell 1995; 83: 59–67
   PubMed Web of Science ®Google Scholar
• Lin C S, Lim S K, D'Agati V, Constantmi F. Differential effects of an erythropoietin receptor gene disruption on primitive and definitive erythropoiesis. Genes Dev 1996; 10: 154–64
   PubMed Web of Science ®Google Scholar
• Wu H, Klingmullcr U, Besmer P, Lodish H F. Interaction of the erythropoietin and stem-cell factor receptors. Nature 1995; 377: 242–6
   PubMed Web of Science ®Google Scholar
• Pharr P N, Hankins D, Hofbauer A, Lodish H F, Longmore G. Expression of a constitutively active erythropoietin receptor in primary hematopoietic progenitors abrogates erythropoietin dependence and enhances CFU-E, BFU-E, and GM progenitor growth. Proc Natl Acad Sci USA 1993; 90: 938–42
   PubMedGoogle Scholar
• Goldsmith M A, Mikami A, You Y, Liu K D, Thomas L, Pharr P, et al. Absence of cytokine receptor-dependent specificity in red blood cell differentiation, in vivo. Proc Natl Acad Sci USA 1998; 95: 7006–11
   PubMed Web of Science ®Google Scholar
• Fairbairn L J, Cowling G J, Reipert B M, Dexter T M. Suppression of apoptosis allows differentiation and development of a multipotent hemopoietic cell line in the absence of added growth factors. Cell 1993; 74: 823–32
   PubMed Web of Science ®Google Scholar
• Ihle J N. Cytokine receptor signaling. Nature 1995; 377: 591–4
   PubMed Web of Science ®Google Scholar
• Kishimoto T, Taga T, Akira S. Cytokine signal transduction. Cell 1994; 76: 253–62
   PubMed Web of Science ®Google Scholar
• Livnah O, Stura E, Middleton S, Johnson D, Jolliffe L, Wilson I. Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation. Science 1999; 283: 987–90
   PubMed Web of Science ®Google Scholar
• Remy I, Wilson I, Michnick S. Erythropoietin receptor activation by a ligand-induced conformation change. Science 1999; 283: 990–3
   PubMed Web of Science ®Google Scholar
• Parganas E, Wang D, Stravapodis D, Topham D J, Marine J-C, Teglund S, et al. Jak2 is essential for signaling through a variety of cytokine receptors. Cell 1998; 93: 385–95
   PubMed Web of Science ®Google Scholar
• Starr R, Willson T, Viney E, Murray L, Rayner J, Jenkins B, et al. A family of cytokine-inducible inhibitors of signaling. Nature 1997; 387: 917–21
   PubMed Web of Science ®Google Scholar
• Naka T, Narazaki M, Hirata M, Matsumoto T, Minamoto S, Aono A, et al. Structure and function of a new STAT-induced STAT inhibitor. Nature 1997; 387: 924–9
   PubMed Web of Science ®Google Scholar
• Endo T, Masuhara M, Yokouchi M, Suzuki R, Sakamoto H, Mitsui K, et al. A new protein containing an SH2 domain that inhibits JAK kinases. Nature 1997; 387: 921–4
   PubMed Web of Science ®Google Scholar
• Jiao H, Berrada K, Yang W, Tabrizi M, Platanias L C, Yi T. Direct association with and dephosphorylation of Jak2 kinase by the SH2-domain-containing protein tyrosine phosphatase SHP-1. Mol Cell Biol 1996; 16: 6985–92
   PubMed Web of Science ®Google Scholar
• Verdier F, Chretien S, Muller O, Varlet P, Yoshimura A, Gisselbrecht S, et al. Proteosomes regulate erythropoietin receptor and signal transducer and activator of transcription 5 (STAT5) activation. J Biol Chem 1998; 273: 28185–90
   PubMed Web of Science ®Google Scholar
• Juvonen E, Ikkala E, Fyhrquist F, Ruutu T. Autosomal dominant erythrocytosis caused by increased sensitivity to erythropoietin. Blood 1991; 78: 3066–9
   PubMed Web of Science ®Google Scholar
• Kravolics R, Divoky M, Stopka T, Prchal J. Low frequency of erythropoietin receptor mutations in subjects with primary familial and congenital polycythemia. Blood 1997; 90: 12a
   Google Scholar
• Arcasoy M, Degar B A, Harris K W, Forget B G. Familial erythrocytosis associated with a short deletion in the erythropoietin receptor gene. Blood 1997; 89: 4628–35
   PubMed Web of Science ®Google Scholar
• Kralovics R, Indrak K, Stopka T, Berman B W, Prchal J F, Prchal J T. Two new EPO receptor mutations: truncated EPO receptors are most frequently associated with primary familial and congenital polycythemias. Blood 1997; 90: 2057–61
   PubMed Web of Science ®Google Scholar
• Kralovics R, Sokol L, Prchal J. Absence of polycythemia in a child with a unique erythropoietin receptor mutation in a family with autosomal dominant primary polycythemia. J Clin Invest 1998; 102: 124–9
   Google Scholar
• de la Chapelle A, Traskelin A-L, Juvonen E. Truncated erythropoietin receptor causes dominantly inherited benign human erythrocytosis. Proc Natl Acad Sci USA 1993; 90: 4495–9
   PubMed Web of Science ®Google Scholar
• Percy M, McMullin M, Roques A, Westwood N, Acharya J, Hughes A, et al. Erythrocytosis due to a mutation in the erythropoietin receptor gene. Br J Haematol 1998; 11: 407–15
   Google Scholar
• Sokol L, Luhovy M, Guan Y, Prchal J F, Semenza G L, Prchal J T. Primary familial polycythemia: a frameshift mutation in the erythropoietin receptor gene and increased sensitivity of erythroid progenitors to erythropoietin. Blood 1995; 86: 15–22
   PubMed Web of Science ®Google Scholar
• Furukawa T, Narita M, Sakaue M, Otsuka T, Kuroha T, Masuko M, et al. Primary familial polycythaemia associated with a novel point mutation in the erythropoietin receptor. Br J Haematol 1997; 99: 222–7
   PubMed Web of Science ®Google Scholar
• Longmore G D. Erythropoietin receptor mutations and Olympic glory. Nat Genet 1993; 4: 108–10
   PubMed Web of Science ®Google Scholar
• D'Andrea A D, Yoshimura A, Youssoufian H, Zon L I, Koo J-W, Lodish H F. The cytoplasmic domain of the erythropoietin receptor contains nonoverlapping positive and negative growth-regulatory domains. Mol Cell Biol 1991; 11: 1980–7
   PubMed Web of Science ®Google Scholar
• Longmore G D, You Y, Molden J, Liu K D, Mikami A, Lai S, et al. Redundant and selective roles for erythropoietin receptor tyrosines in erythropoiesis in vivo. Blood 1998; 91: 870–8
   Google Scholar
• Chida D, Miura O, Yoshimura A, Miyajima A. Role of cytokine signaling molecules in erythroid differentiation of mouse fetal liver hematopoietic cells: functional analysis of signaling molecules by retroviral-mediated expression. Blood 1999; 93: 1567–78
   PubMedGoogle Scholar
• Klingmuller U, Lorenz U, Cantley L C, Neel B G, Lodish H F. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell 1995; 80: 729–38
   PubMed Web of Science ®Google Scholar
• Shultz L D, Schweitzer P A, Rajan T V, Yo T, Ihle J N, Matthews J, et al. Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene. Cell 1993; 1445–54
   Google Scholar
• van Zant G, Shultz L. Hematologic abnormalities of the immunodeficient mouse mutant, viable motheaten. Exp Hematol 1989; 17: 81–7
   PubMed Web of Science ®Google Scholar
• Matsumoto A, Masuhara M, Mitsui K, Yokouchi M, Ohtsubo M, Misawa H, et al. CIS, a cytokine inducible SH2 protein, is a target of the JAK-STA5 pathway and modulates STAT5 activation. Blood 1997; 89: 3148–54
   PubMed Web of Science ®Google Scholar
• Miura Y, Miura O, Ihle J N, Aoki N. Activation of the mitogen-activated protein kinase pathway by the erythropoietin receptor. J Biol Chem 1994; 269: 29962–9
   PubMedGoogle Scholar
• Poliakova L A. Familial erythrocytosis among the residents of the Chuvash ASSR (in Russian). Probl Gematol Pereliv Krovi 1974; 19: 30–3
   Google Scholar
• Sergeyeva A, Gordeuk V R, Tokarev Y N, Sokol L, Prchal J F, Prchal J T. Congenital polycythemia in Chuvashia. Blood 1997; 89: 2148–54
   PubMed Web of Science ®Google Scholar
• Anagnostou A, Lee E S, Kessimian N, Levinson R, Steiner M. Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells. Proc Natl Acad Sci USA 1990; 87: 5978–82
   PubMed Web of Science ®Google Scholar
• Yoshimura A, Longmore G, Lodish H F. Point mutation in the exoplasmic domain of the erythropoietin receptor resulting in hormone-independent activation and tumori-genicity. Nature 1990; 348: 647–9
   PubMed Web of Science ®Google Scholar
• Longmore G D, Lodish H F. An activating mutation in the murine erythropoietin receptor induces erythroleukemia in mice: a cytokine receptor superfamily oncogene. Cell 1991; 67: 1089–102
   PubMed Web of Science ®Google Scholar
• Longmore G D, Pharr P, Neumann D, Lodish H F. Both megakaryocytopoiesis and erythropoiesis are induced in mice infected with a retrovirus expressing an oncogenic erythropoietin receptor. Blood 1993; 82: 2386–95
   PubMed Web of Science ®Google Scholar
• Hess G, Rose P, Gamm H, Papadileris S, Huber C, Seliger B. Molecular analysis of the erythropoietin receptor system in patients with polycythemia vera. Br J Haematol 1994; 88: 794–802
   PubMedGoogle Scholar
• Le Couedic J-P, Mitjavila M-T, Villeval J-L, Feger F, Gobert S, Mayeux P, et al. Missense mutation of the erythropoietin receptor is a rare event in human erythroid malignancies. Blood 1996; 87: 1502–10
   Google Scholar
• Nakamura Y, Komatsu M, Nakauchi H. A truncated erythropoietin receptor that fails to prevent programmed cell death of erythroid cells. Science 1992; 257: 1138–42
   PubMed Web of Science ®Google Scholar
• Chiba S, Takahashi T, Takeshita K, Minowada J, Yazaki Y, Ruddle F, et al. Selective expression of mRNA coding for the truncated form of erythropoietin receptor in hematopoietic cells and its decrease in patients with polycythemia vera. Blood 1997; 90: 97–104
   Google Scholar
• Haber D, Harlow E. Tumour-suppressor genes: evolving definitions in the genomic age. Nat Genet 1997; 16: 320–2
   PubMed Web of Science ®Google Scholar
• Moliterno A, Hankins D, Spivak J. Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera. N Engl J Med 1998; 338: 572–80
   PubMed Web of Science ®Google Scholar
• Kaushansky K. Thrombopoietin: the primary regulator of platelet production. Blood 1995; 86: 419–31
   PubMed Web of Science ®Google Scholar
• Carver-Moore K, Broxmeyer H, Luoh S-M, Cooper S, Peng J, Burstein S, et al. Low levels of erythroid and myeloid progenitors in thrombopoietin- and c-mpl-deficient mice. Blood 1996; 88: 803–8
   PubMed Web of Science ®Google Scholar
• Cocault L, Bouscary D, Bousse Kardiles C, Clay D, Picard F, Gisselbrecht S, et al. Ectopic expression of murine TPO receptor (c-mpl) in mice is pathogenic and induces erythroblastic proliferation. Blood 1996; 88: 1656–65
   PubMed Web of Science ®Google Scholar
• Kieran M, Perkins A, Orkin S, Zon L. Thrombopoietin rescues in vitro erythroid colony formation from embryos lacking the erythropoietin receptor. Proc Natl Acad Sci USA 1996; 93: 9126–31
   PubMed Web of Science ®Google Scholar
• Westwood N B, Copson E R, Page L A, Mire-Sluis A R, Brown K A, Pearson T C. Activated phenotype in neutrophils and monocytes from patients with primary proliferative polycythemia. J Clin Pathol 1995; 48: 525–30
   PubMed Web of Science ®Google Scholar
• Cashman J, Henkelman D, Humphries K, Eaves C, Eaves A. Individual BFU-E in polycythemia vera produce both erythropoietin dependent and independent progeny. Blood 1983; 61: 876–84
   Google Scholar
• de Wolf J T, Beentjes J A, Esselink M T, Smit J W, Halie R M, Clark S C, et al. In polycythemia vera human interleukin 3 and granulocyte-macrophage colony-stimulating factor enhance erythroid colony growth in the absence of erythropoietin. Exp Hetnatol 1989; 17: 981–3
   PubMed Web of Science ®Google Scholar
• Dai C H, Krantz S B, Green W F, Gilbert H S. Polycythemia vera. III. Burst-forming units-erythroid (BFU-E) response to stem cell factor and c-kit receptor expression. Br J Haematol 1994; 86: 12–21
   PubMed Web of Science ®Google Scholar
• Correa P N, Eskinazi D, Axelrad A A. Circulating erythroid progenitors in polycythemia vera are hypersensitive to insulin-like growth factor-1 in vitro: studies in an improved serum-free medium. Blood 1994; 83: 99–112
   PubMed Web of Science ®Google Scholar
• Asimakopoulos F A, Hinshelwood S, Gilbert J G, Delibrias C C, Gottgens B, Fearon D T, et al. The gene encoding hematopoietic cell phosphatase (SHP-1) is structurally and transcriptionally intact in polycythemia vera. Oncogene 1997; 14: 1215–22
   Google Scholar
• Andersson P, LeBlanc K, Eriksson B A, Samuelsson J. No evidence for an altered mRNA expression or protein level of haematopoietic cell phosphatase in CD34+ bone marrow progenitor cells or mature peripheral blood cells in poiy-cythaemia vera. Eur J Haematol 1997; 59: 310–7
   PubMed Web of Science ®Google Scholar
• Dai C H, Krantz S B, Sawyer S T. Polycythemia vera. V. Enhanced proliferation and phosphorylation due to vanadate are diminished in polycythemia vera erythroid progenitor cells: a possible defect of phosphatase activity in polycythemia vera. Blood 1997; 89: 3574–81
   Google Scholar
• Sui X, Krantz S B, Zhao Z. Identification of increased protein tyrosine phosphatase activity in polycythemia vera erythroid progenitor cells. Blood 1997; 90: 651–7
   Google Scholar
• Koury M, Bondurant M. Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells. Science 1990; 248: 378–81
   PubMed Web of Science ®Google Scholar
• Gregoli P, Bondurant M. The roles of Bcl-xL and apopain in the control of erythropoiesis by erythropoietin. Blood 1997; 90: 630–40
   PubMed Web of Science ®Google Scholar
• Silva M, Grillot D, Benito A, Richard C, Nunez G, Fernandez-Luna J. Erythropoietin can promote erythroid progenitor survival by repressing apoptosis through Bcl-XL and Bcl-2. Blood 1996; 88: 1576–82
   PubMed Web of Science ®Google Scholar
• Silva M, Richard C, Benito A, Sanz C, Olalla I, Fernandez-Luna J. Expression of Bcl-x in erythroid precursors from patients with polycythemia vera. N Engl J Med 1998; 338: 568–71
   Google Scholar
• Mitjavila M T, Le Couedic J P, Casadevall N, Navarro S, Villeval J L, Dubart A, et al. Autocrine stimulation by erythropoietin and autonomous growth of human erythroid leukemic cells in vitro. J Clin Invest 1991; 88: 789–97
   PubMed Web of Science ®Google Scholar
• Li J P, D'Andrea A D, Lodish H E, Baltimore D. Activation of cell growth by binding of Friend spleen focus-forming virus gp55 glycoprotein to the erythropoietin receptor. Nature 1990; 343: 762–4
   PubMed Web of Science ®Google Scholar
• Ben-David Y, Bernstein A. Friend virus-induced erythro-leukemia and the multistage nature of cancer. Cell 1991; 66: 831–4
   PubMed Web of Science ®Google Scholar
• Watowich S S, Yoshimura A, Longmore G D, Hilton D, Yoshimura Y, Lodish H F. Homodimerization and constitutive activation of the erythropoietin receptor. Proc Natl Acad Sci USA 1992; 89: 2140–4
   PubMed Web of Science ®Google Scholar
• Longmore G D, Pharr P N, Lodish H F. A constitutively activated erythropoietin receptor stimulates proliferation and contributes to transformation of multipotent, committed nonerythroid and erythroid progenitor cells. Mol Cell Biol 1994; 14: 2266–77
   PubMed Web of Science ®Google Scholar
• Ward J C, Harris K W, Penny L A, Forget B G, Kitamura T, Winkelmann J C. A structurally abnormal erythropoietin receptor gene in a human erythroleukemia cell line. Exp Hematol 1992; 20: 371–3
   PubMed Web of Science ®Google Scholar
• Winkelmann J C, Ward J, Mayeux P, Lacombe C, Schimmenti L, Jenkins R B. A translocated erythropoietin receptor gene in a human erythroleukemia cell line (TF-1) expresses an abnormal transcript and a truncated protein. Blood 1995; 85: 179–85
   PubMed Web of Science ®Google Scholar
• Dianzani I, Garelli E, Dompe C, Crescenzio N, Locatelli F, Schiliro G, et al. Mutations in the erythropoietin receptor gene are not a common cause of Diamond-Blackfan anemia. Blood 1996; 87: 2568–72
   PubMed Web of Science ®Google Scholar
• Gustavsson P, Garelli E, Draptchinskaia N, Ball S, Willig T, Tender D, et al. Identification of microdeletions spanning the Diamond-Blackfan anemia locus on 19q13 and evidence for genetic heterogeneity. Am J Hum Genet 1998; 63: 1388–95
   Google Scholar
• Draptchinskaia N, Gustavsson P, Andersson B, Pettersson M, Willig T, Dianzani I, et al. The gene encoding ribosomal protein S19 is mutated in Diamond-Blackfan anaemia. Nat Genet 1999; 21: 169–75
   PubMed Web of Science ®Google Scholar